Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950123-05-000862
Filing Date
2005-01-28
Accepted
2005-01-28 17:20:05
Documents
1
Period of Report
2005-03-16
Effectiveness Date
2005-01-28

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. y04649def14a.txt DEF 14A 181777
  Complete submission text file 0000950123-05-000862.txt   183485
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: DEF 14A | Act: 34 | File No.: 000-15190 | Film No.: 05559267
SIC: 2835 In Vitro & In Vivo Diagnostic Substances